Acrux Limited (ACR.AX)

AUD 0.03

(-5.71%)

EBITDA Summary of Acrux Limited

  • Acrux Limited's latest annual EBITDA in 2024 was -7.93 Million AUD , down -188.55% from previous year.
  • Acrux Limited's latest quarterly EBITDA in 2024 FY was N/A , down -188.55% from previous quarter.
  • Acrux Limited reported an annual EBITDA of -2.79 Million AUD in 2023, up 77.29% from previous year.
  • Acrux Limited reported an annual EBITDA of -12.28 Million AUD in 2022, up 21.04% from previous year.
  • Acrux Limited reported a quarterly EBITDA of N/A for 2024 FY, down -188.55% from previous quarter.
  • Acrux Limited reported a quarterly EBITDA of -4.36 Million AUD for 2024 Q4, down 0.0% from previous quarter.

Annual EBITDA Chart of Acrux Limited (2024 - 2002)

Historical Annual EBITDA of Acrux Limited (2024 - 2002)

Year EBITDA EBITDA Growth
2024 -7.93 Million AUD -188.55%
2023 -2.79 Million AUD 77.29%
2022 -12.28 Million AUD 21.04%
2021 -15.58 Million AUD -37.09%
2020 -11.36 Million AUD 10.28%
2019 -12.67 Million AUD -35.84%
2018 -9.32 Million AUD -183.15%
2017 12.12 Million AUD -41.03%
2016 20.79 Million AUD 12.22%
2015 16.95 Million AUD -62.52%
2014 45.23 Million AUD 315.5%
2013 10.88 Million AUD 200.88%
2012 3.61 Million AUD -95.67%
2011 83.55 Million AUD 67.49%
2010 49.88 Million AUD 600.12%
2009 -9.97 Million AUD -41.09%
2008 -6.41 Million AUD 24.19%
2007 -9.32 Million AUD 20.85%
2006 -11.78 Million AUD -109.54%
2005 -6.93 Million AUD -42.36%
2004 -3.95 Million AUD 30.77%
2003 -5.7 Million AUD -51.21%
2002 -3.77 Million AUD 0.0%

Peer EBITDA Comparison of Acrux Limited

Name EBITDA EBITDA Difference
EZZ Life Science Holdings Limited 10.37 Million AUD 176.44%
Anatara Lifesciences Ltd -1.45 Million AUD -444.463%
Zelira Therapeutics Limited -36.44 Million AUD 78.236%
Biome Australia Limited -1.57 Million AUD -402.518%
Patrys Limited -3.49 Million AUD -127.109%
Orthocell Limited -11.68 Million AUD 32.104%
Imugene Limited -147.97 Million AUD 94.64%
Noxopharm Limited -5.94 Million AUD -33.395%
PYC Therapeutics Limited -38.11 Million AUD 79.193%
Chimeric Therapeutics Limited -11.29 Million AUD 29.813%
Prescient Therapeutics Limited -7.18 Million AUD -10.372%
Proteomics International Laboratories Limited -7.88 Million AUD -0.554%
Cynata Therapeutics Limited -9.95 Million AUD 20.293%
CSL Limited 4.73 Billion AUD 100.168%
Arovella Therapeutics Limited -8.83 Million AUD 10.213%
Bio-Gene Technology Limited -2.97 Million AUD -166.589%
Clinuvel Pharmaceuticals Limited 51.86 Million AUD 115.292%
Starpharma Holdings Limited -12.57 Million AUD 36.94%
Nanollose Limited -1.14 Million AUD -590.913%
Memphasys Limited -3.3 Million AUD -139.772%
Invex Therapeutics Ltd -720.44 Thousand AUD -1000.854%
NeuroScientific Biopharmaceuticals Limited -1.79 Million AUD -341.522%
Amplia Therapeutics Limited -4.55 Million AUD -73.941%
Botanix Pharmaceuticals Limited -13.91 Million AUD 43.022%
Island Pharmaceuticals Limited -2.81 Million AUD -181.429%
Race Oncology Limited -14.2 Million AUD 44.161%
Nyrada Inc. -4.59 Million AUD -72.556%
Telix Pharmaceuticals Limited 22.96 Million AUD 134.534%
Dimerix Limited -24.95 Million AUD 68.223%
PharmAust Limited -9.45 Million AUD 16.089%
Immutep Limited -42.87 Million AUD 81.502%
Clarity Pharmaceuticals Ltd -44.64 Million AUD 82.236%
Alterity Therapeutics Limited -19.57 Million AUD 59.477%
BTC Health Limited 1.05 Million AUD 851.549%
Neuren Pharmaceuticals Limited 199.26 Million AUD 103.98%
Biotron Limited -5.04 Million AUD -57.359%
Tissue Repair Ltd -5.77 Million AUD -37.333%
AdAlta Limited -5.3 Million AUD -49.565%
Radiopharm Theranostics Limited -45.37 Million AUD 82.522%
Hexima Limited -995.54 Thousand AUD -696.651%
AnteoTech Limited -11.57 Million AUD 31.458%
Paradigm Biopharmaceuticals Limited -64.53 Million AUD 87.711%
Recce Pharmaceuticals Ltd -21.35 Million AUD 62.86%
Avecho Biotechnology Limited -3.24 Million AUD -144.594%
Actinogen Medical Limited -12.92 Million AUD 38.62%
Immuron Limited -6.19 Million AUD -28.077%
Argenica Therapeutics Limited -1.89 Million AUD -317.951%